Small Molecules

PX-866

Development Status Oncothyreon's clinical development program for PX-866, which includes Phase 1 / 2 and Phase 2 clinical trials currently underway, is designed to examine multiple tumor indications and evaluate PX-866 both alone and in combination with other therapies. For more information regarding PX-866 clinical trials, please see the Clinical Trials page. return to top ^